枸橼酸托法替尼【540737-29-9】产品图
文献支持

枸橼酸托法替尼【540737-29-9】

收藏
  • ¥132 - 2304
  • TargetMol
  • T2398
  • 2026年07月07日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • CAS号:

      540737-29-9

    • 规格:

      1mLx10mM(inDMSO)/1mg/5mg/10mg/25mg/50mg/100mg/200mg

    规格:1mLx10mM(inDMSO)产品价格:¥290.0
    规格:1mg产品价格:¥132.0
    规格:5mg产品价格:¥253.0
    规格:10mg产品价格:¥396.0
    规格:25mg产品价格:¥662.0
    规格:50mg产品价格:¥984.0
    规格:100mg产品价格:¥1584.0
    规格:200mg产品价格:¥2304.0

    Product Introduction

    Bioactivity

    名称 Tofacitinib Citrate
    描述 Tofacitinib Citrate (CP-690550 citrate) is a a potent, cell-permeable inhibitor of JAK1/2/3 (IC50s: 1/20/112 nM).
    细胞实验 Apoptotic cells were detected by flow cytometry using recombinant human Annexin-V conjugated with allophycocyanin. Briefly, after exposure to CP-690,550 for different periods of time, cells were washed in Ca2+-free PBS and resuspended in 100 μL of binding buffer (10 mM HEPES pH 7.4; 0.15 M NaC1; 5 mM KCl; 1 mM MgCl2; 1.8 mM CaCl2) to which Annexin-V-APC had been previously added. Cells were incubated for 20 min in the dark at room temperature, washed and resuspended in 0.3 mL binding buffer. Cells were analyzed on a FACSCalibur flow cytometer equipped with the Cell Quest Pro software [2].
    激酶实验 The JAK1, JAK2, and JAK3 kinase assays utilize a protein expressed in baculovirus-infected SF9 cells (a fusion protein of GST and the catalytic domain of human JAK enzyme) purified by affinity chromatography on glutathione sepharose. The substrate for the reaction was polyglutamic acid-tyrosine [PGT (4:1)], coated onto Nunc Maxi Sorp plates at 100 μg/mL overnight at 37 °C. The plates were washed three times, and JAK enzyme was added to the wells, which contained 100 μL of kinase buffer (50 mM HEPES, pH 7.3, 125 mM NaCl, 24 mM MgCl2) + ATP + 1 mM sodium orthovanadate). After incubation at room temperature for 30 min, the plates were washed three times. The level of phosphorylated tyrosine in a given well was determined by standard ELISA assay utilizing an anti-phosphotyrosine antibody [5].
    动物实验 Mice received tofacitinib in PEG300 (100 mg/ml) or vehicle alone (PEG300) by osmotic pump infusion (Alzet Model 2004, 0.25 μl/hour, 28 days). Four days prior to immunization, mice were anesthetized and their dorsal surface was shaved. A one cm incision was made on the back to create a subcutaneous pocket and insert the pump. The incision site was closed with wound clips. Mice were injected weekly (i.p.) with SS1P recombinant immunotoxin (RIT; 5 μg/mouse) beginning on day 0; control mice received injections of saline alone. Every week before SS1P or vehicle immunization, ~50 μl of blood was drawn to obtain serum samples. Sera were stored at ?80°C until analyzed [4].
    体外活性 虽然Tofacitinib (CP-690,550) 对JAK3的抑制作用极为强大(酶抑制效力为1 nM),但其对JAK2和JAK1的抑制作用分别低20至100倍。CP-690,550能以比对GM-CSF诱导的增殖30倍更强的效力抑制IL-2诱导的增殖。CP-690,550在使用鼠、猴或人细胞的混合淋巴细胞反应中展现出强大的抑制效果。与其作用机制一致,这些细胞活性与CP-690,550阻断IL-2诱导的JAK3及其关键底物STAT5的磷酸化能力相关[1]。在治疗含有人类野生型或V617F JAK2的鼠类因子依赖细胞Patersen-erythropoietin receptor (FDCP-EpoR)时,CP-690,550能抑制细胞增殖,其IC50分别为2.1 μg/ml和0.25 μg/ml。对JAK2(V617F)-阳性PV患者体外扩增的红细胞祖细胞进行CP-690,550治疗,表现出特异的抗增殖(IC50:0.2 μg/ml)和促凋亡活性[2]。Tofacitinib对JAK3的药理抑制作用与IMA在CML细胞中的抗肿瘤效果协同增强[3]。
    体内活性 CP-690,550治疗显著延长了与对照组相比的移植物存活时间。12只动物中有4只接受CP-690,550治疗(每个剂量组各两只)存活至研究结束,且肾功能正常,根据组织病理学判断只有轻度排斥反应[1]。用tofacitinib单药治疗小鼠能够抑制对由细菌蛋白质Pseudomonas exotoxin A衍生的免疫毒素以及模型抗原钥孔血蓝蛋白的抗体(Ab)反应。实验显示,在免疫后21天观察到对两种抗原IgG1滴度的千倍降低。Tofacitinib治疗还导致CD127+前B细胞数量减少[4]。
    存储条件 Store at low temperature,Keep away from moisture,Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
    溶解度 10% DMSO+90% Saline : 10 mg/mL (19.82 mM), Solution.
    10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (3.96 mM), Sonication is recommended.
    DMSO : 250 mg/mL (495.55 mM), Sonication is recommended.
    关键字 Tofacitinib Citrate | Tofacitinib | Tasocitinib Citrate | Tasocitinib | Janus kinase | JAK3 | JAK2 | JAK1 | JAK | Inhibitor | inhibit | InfluenzaVirus | Influenza Virus | Fungal | CP-690550 Citrate | CP690550 Citrate | CP-690550 | CP690550 | CP 690550 Citrate | CP 690550 | Bacterial | Apoptosis
    相关产品 Formamide | Aceglutamide | Calcium Propionate | Benzyl propionate | Neomycin sulfate | Terbinafine hydrochloride | Dimethyl sulfoxide | Sodium bicarbonate | Hyaluronic acid sodium (MW 20 kDa) | Sodium diacetate | Sulfamethoxazole sodium | D(+)-Raffinose pentahydrate
    相关库 Inhibitor Library | Bioactive Compound Library | Anti-Fungal Compound Library | Bioactive Compounds Library Max | EMA Approved Drug Library | Anti-Aging Compound Library | FDA-Approved Drug Library | Anti-Viral Compound Library | Immunology/Inflammation Compound Library | Membrane Protein-targeted Compound Library | Tyrosine Kinase Inhibitor Library | Anti-Cancer Clinical Compound Library

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    官网有文献
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥117
    广州市左克生物科技发展有限公司
    2026年07月22日询价
    ¥884.99
    北京德航五洲科技有限公司
    2025年07月12日询价
    ¥419
    爱必信(上海)生物科技有限公司
    2026年05月27日询价
    ¥110
    北京沃比森科技有限公司
    2025年11月10日询价
    文献支持
    枸橼酸托法替尼【540737-29-9】
    ¥132 - 2304